Mondays to Thursdays from 8:00-15:30,

Fridays from 8:00-14:00

The diagnosis and treatment of the entire spectrum of rheumatic-inflammatory (rheumatism) and autoimmune diseases, including severe organ manifestations and complications, is the focus of our outpatient care and patient support. Affected patients or their treating physicians can make an appointment with our outpatient team by telephone if required.

Monday to Friday by individual arrangement

Operations on all benign and malignant diseases/cancers of the stomach, oesophagus, liver, gallbladder, bile ducts and pancreas, small and large intestine. This includes the following diseases

• bowel cancer
• stomach cancer
• pancreatic cancer
• Pancreatic cancer
• liver cancer
• Esophageal cancer
• Hepatocellular cancer
• Small intestine cancer
• Colon cancer
• Gallbladder cancer
• Bile duct cancer
• Liver metastases
• HCC
• CCC
• Klatskin tumors

Liver adenomas, hemangiomas and FNH (follicular nodular hyperplasia), sigmoid diverticulitis, hemorrhoids, anal fissures, FAP, chronic inflammatory bowel disease, Crohn's disease and ulcerative colitis are also treated.

Mondays to Thursdays 13:00 - 14:30 and Fridays 12:00 - 13:00

Patients with the following diseases are treated at the Skin Tumor Center Hannover:

• Malignant melanoma ("black skin cancer")
• Basal cell carcinoma and squamous cell carcinoma with its precursors ("white skin cancer")
• Mycosis fungoides and other lymphomas of the skin
• Merkel cell carcinoma
• Dermatofibrosarcoma protuberans
• Angiosarcoma, Kaposi's sarcoma and other rare tumors of the skin
• Benign neoplasms of the skin
• Cutaneous lymphoma

Appointments by appointment

• Telephone availability:
  Mondays to Fridays 08:30-13:00

In our gynecological oncology outpatient clinic, we advise patients with breast cancer, ovarian cancer, cervical cancer, uterine cancer or other rare gynecological cancers for the purpose of treatment planning.

Our range of treatments includes:

• Chemotherapy,
• anti-hormonal therapy,
• antibody therapy (e.g. trastuzumab, bevacizumab),
• "targeted therapy", i.e. targeted therapy with "biologicals" (e.g. lapatinib)